Navigation Links
India Fast Become Prime Location for Clinical Trials, but Vigilance Called for

India is fast becoming a prime location for clinical trials for many pharmaceutical giants//, observers say.

Pfizer, BristolMyers Squibb, GlaxoSmithkline, Eli Lilly are among those big firms that conduct the trials in the country.

Currently over 226 clinical trials approved by the U.S. Food and Drug Administration (FDA) are in India.

Faced with the increasing costs of clinical trials and a shortage of willing participants at home, western drug companies are looking at off-shoring the trials to the third world.

India has perhaps the world's largest patient pool, it is pointed out. Moreover, it may be easy to pick out those who may not be taking any other medicine.

But the main consideration is costs — industry watchers say drug companies may save up to 50% of the costs of new drug development by conducting trials in India.

Big cities are favorite spots for these trials, with Delhi having 76 trials, Mumbai 86, Chennai 50 and Bangalore 64, it is reported.

Many clinical research organizations (CROs) have sprouted up, offering to carry out such trials. They are getting business worth up to 120 million US dollars a year. It is expected that clinical trials estimated to cost two billion dollars could end up in India by 2010.

The Center has made changes in laws and regulations to accommodate the clinical trial boom.

Apart from changes in patent laws, which will protect data confidentiality, initial or phase-1 trials are also permitted.

A Framework for Good Clinical Practices has also been announced. In the budget for 2007-08, the service tax on clinical trials was done away with.

However, many doubt whether India's top regulatory body, the Drug Controller General of India, is technically equipped to cope with the influx.

In recent years, there has been a spate of failures of clinical trials with many of the top pharma compani es being forced to withdraw drugs after adverse reports. While Bristol-Myers Squibb terminated a new diabetes drug, Astra Zeneca halted work on a new drug for stroke patients. And Pfizer did so with its cholesterol-reducing Torcetrapib.

They all pull out only on realizing irreversible damage has been caused to the subjects. But no one will compensate them or their families.

Necessary measures to protect the health of the Indian citizens should be put in place first, urge activists. That is far more important than earning dollars, they stress.
'"/>




Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. AIDS Disaster in India is Imminent
3. Indian Prime Minister has successful Knee Replacement Surgery
4. International community warns India on HIV situation
5. India takes on foot-and-mouth disease by vaccinating animals
6. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
7. India to benefit from pharma companies move
8. Healthcare sector is now a multi billion-dollar industry in India
9. The World Bank funds private Hospital in India
10. Parke-Davis (India) runs into rough weather – Court orders attachment of asset
11. Indian Doctor granted US patent on organ regeneration
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Lafayette, California (PRWEB) , ... ... ... a pioneer in the patient payment industry today announced its strategic partnership ... and health system workflows. , The two companies’ proven, proprietary technology combine ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer ... they remain in the eye of the beholder, according to experts who offered insights ... American Journal of Managed Care. For the full issue, click here . , ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
Breaking Medicine Technology: